Analysis Of Income And Expense [Abstract]

PureTech Health plc - Filing #2024169

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
Analysis of income and expense [abstract]
Revenue [abstract]
Revenue
3,330,000 USD
15,618,000 USD
17,388,000 USD
Material income and expense [abstract]
Gains (losses) on disposals of investments [abstract]
Losses on disposals of investments
122,000 USD
29,303,000 USD
20,925,000 USD
Research and development expense
96,235,000 USD
152,433,000 USD
110,471,000 USD
Finance income (cost)
5,078,000 USD
138,924,000 USD
5,050,000 USD
Other operating income (expense)
111,072,000 USD
25,981,000 USD
159,983,000 USD
Selling, general and administrative expense [abstract]
General and administrative expense
53,295,000 USD
60,991,000 USD
57,199,000 USD
Share of profit (loss) of associates and joint ventures accounted for using equity method [abstract]
Share of profit (loss) of associates and joint ventures accounted for using equity method
6,055,000 USD
27,749,000 USD
73,703,000 USD
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income
66,535,000 USD
931,000 USD
65,697,000 USD
65,604,000 USD
92,000 USD
50,733,000 USD
37,444,000 USD
50,354,000 USD
13,290,000 USD
379,000 USD
2,151,000 USD
60,558,000 USD
62,709,000 USD
60,558,000 USD
Comprehensive income attributable to owners of parent, continuing and discontinued operations [abstract]
Comprehensive income, attributable to owners of parent
65,604,000 USD
50,733,000 USD
60,558,000 USD
Comprehensive income attributable to non-controlling interests, continuing and discontinued operations [abstract]
Comprehensive income, attributable to non-controlling interests
931,000 USD
13,290,000 USD
2,151,000 USD

Talk to a Data Expert

Have a question? We'll get back to you promptly.